polatuzumab vedotin (Polivy) Report issue

Biologics mAb ADC Orphan Drug FDA Approved FDA First in Class Accelerated Approval FDA
AACT ChEMBL DrugBank MeSH
Back

Drug Pricing Summary

VA Big4

$2454.0600 - $11105.4700

VA FSS

$3190.9900 - $15000.0000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
polatuzumab vedotin 140 mg / 7.52 mL (7.5 mL INJECTION) $11105.4700 VA Big4
  • POLIVY (1)
    		•  Genentech USA
    polatuzumab vedotin 140 mg / 7.52 mL (7.5 mL INJECTION) $15000.0000 VA FSS
  • POLIVY (1)
    		•  Genentech USA
    polatuzumab vedotin 30 mg / 1.88 mL (1.9 mL INJECTION) $2454.0600 VA Big4
  • POLIVY (1)
    		•  Genentech USA
    polatuzumab vedotin 30 mg / 1.88 mL (1.9 mL INJECTION) $3190.9900 VA FSS
  • POLIVY (1)
    		•  Genentech USA

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue